We also confirmed that AZD4573 resulted in the glycolysis inhibition of B-ALL cells by degrading CDK9 and phosphorylating serine 2 and 5 in the CTD of RNA Pol II (Supplementary Figure 2). Here, CDK9 is linked to precursor B-cell acute lymphoblastic leukemia.